Through long-term, strategic partnerships, Philips is working with healthcare systems across the country to understand work flows and remove complexity to deliver a seamless approach to wellness when, where, and how people need it. This approach is critical for value-based care. As part of these relationships, Philips co-creates intelligent innovations with its partners, many of which benefit from “adaptive intelligence,” the Philips application of artificial intelligence that improves people’s lives in a meaningful way. Examples of Philips solutions that apply adaptive intelligence include Illumeo and IntelliVue Guardian EWS. This combination of artificial intelligence with deep knowledge of the clinical, operational, and personal context supports solutions that adapt to people’s needs and help healthcare providers achieve better outcomes at lower cost. This approach is validated by the findings in the FHI, which shows the U.S. investment in artificial intelligence (AI) is double the average spend in AI related to preliminary diagnosis ($0.06 per capita vs $0.03 on average) and therapy planning ($0.14 per capita vs $0.06 on average), which suggests a prioritization of healthcare AI technologies in the U.S. market.
About the Future Health Index

Ad Statistics
Times Displayed: 19863
Times Visited: 567 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
The first of three independent chapters scheduled for release over the year, the report defines a model for measuring value as it relates to value-based healthcare and assesses the value present in several international healthcare systems.
The Future Health Index 2018 analyzes primary research and third party data from across 16 countries, representing about half of the world’s population. The Index also provides an indicator of the value delivered by individual healthcare systems. The Value Measure provides a benchmark against which a system’s progress towards value-based care can be evaluated. In addition, the report includes input from global healthcare experts which provides actionable insights for countries to improve the value their health systems deliver.
About Royal Philips
Royal Philips (NYSE:PHG, AEX:PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2017 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries.
Back to HCB News